Source Paper
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
M Olsson, G Nikkhah, C Bentlage, A Bjorklund
Journal of Neuroscience • 1995
Source Paper
M Olsson, G Nikkhah, C Bentlage, A Bjorklund
Journal of Neuroscience • 1995
Methods for the assessment of akinesia in the unilateral rat Parkinson model have so far been lacking. The experiments reported here evaluate the usefulness of a new “stepping test” to monitor forelimb akinesia in rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the mesencephalic dopamine (DA) system, and to assess the ability of DA- receptor agonists and fetal DA neuron transplants to reverse these deficits. The 6-OHDA lesion induced marked and long-lasting impairments in the initiation of stepping movements with the contralateral paw. Systemic injections of low doses (chosen to be subthreshold for induction of rotation) of the mixed D1 and D2 receptor agonist apomorphine, the D1-selective agonist SKF 38393, and to a lesser extent also the D2-selective agonist quinpirole were effective in reversing these deficits. Similar effects was seen after a subrotational dose of L-dopa, whereas amphetamine had no effect. Fetal nigral transplants, implanted as multiple deposits in the ipsilateral caudate-putamen and substantia nigra, restored initiation of stepping to a similar degree as the DA agonists. Nigral grafts placed in substantia nigra alone were also effective, although the improvement was less pronounced. Apomorphine, at a dose effective in the lesion-only animals, had no additive effect in the grafted rats, whereas amphetamine appeared to further improve stepping in the rats with intranigral transplants. Identical experiments were performed on skilled forelimb use in the so- called staircase test. Interestingly, neither the DA agonist drugs nor the nigral transplants had any effects on the lesion induced deficits in this more complex task. The results show that forelimb stepping is a highly useful test to monitor lesion-/and transplant-induced changes in forelimb akinesia, a behavioral parameter that may be analogous to limb akinesia and gait problems seen in patients with Parkinson's disease.
Objective: To assess forelimb akinesia and stepping movements in rats with unilateral 6-OHDA lesions of the dopamine system, and to evaluate the effectiveness of dopamine agonists and fetal dopamine neuron transplants in reversing these deficits
This is a Stepping Test protocol using rat as the model organism. The procedure involves 12 procedural steps, 2 equipment items, 7 materials. Extracted from a 1995 paper published in Journal of Neuroscience.
Model and subjects
rat • Not specified • unknown • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Create unilateral 6-OHDA lesion • Administer dopamine agonist - Apomorphine • Administer dopamine agonist - SKF 38393
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Induce unilateral 6-hydroxydopamine lesion of the mesencephalic dopamine system in rats
Note: This creates the Parkinson model with marked and long-lasting impairments in stepping movements with the contralateral paw
“The 6-OHDA lesion induced marked and long-lasting impairments in the initiation of stepping movements with the contralateral paw”
Systemically inject low doses of apomorphine (mixed D1 and D2 receptor agonist) chosen to be subthreshold for induction of rotation
Note: Apomorphine was effective in reversing stepping deficits
“Systemic injections of low doses (chosen to be subthreshold for induction of rotation) of the mixed D1 and D2 receptor agonist apomorphine”
Systemically inject low doses of SKF 38393 (D1-selective agonist) chosen to be subthreshold for induction of rotation
Note: SKF 38393 was effective in reversing stepping deficits
“the D1-selective agonist SKF 38393, and to a lesser extent also the D2-selective agonist quinpirole were effective in reversing these deficits”
Systemically inject low doses of quinpirole (D2-selective agonist) chosen to be subthreshold for induction of rotation
Note: Quinpirole was less effective than D1-selective agonist but still effective in reversing stepping deficits
“the D2-selective agonist quinpirole were effective in reversing these deficits”
Systemically inject a subrotational dose of L-dopa
Note: Similar effects to dopamine agonists were observed
“Similar effects was seen after a subrotational dose of L-dopa”
Systemically inject amphetamine
Note: Amphetamine had no effect on stepping deficits in lesion-only animals but appeared to further improve stepping in rats with intranigral transplants
“whereas amphetamine had no effect”
Implant fetal dopamine neuron transplants as multiple deposits in the ipsilateral caudate-putamen and substantia nigra
Note: Transplants restored initiation of stepping to a similar degree as dopamine agonists
“Fetal nigral transplants, implanted as multiple deposits in the ipsilateral caudate-putamen and substantia nigra, restored initiation of stepping”
Implant fetal dopamine neuron transplants in substantia nigra alone as an alternative placement
Note: Nigral grafts placed in substantia nigra alone were also effective, although improvement was less pronounced than multiple deposits
“Nigral grafts placed in substantia nigra alone were also effective, although the improvement was less pronounced”
Administer apomorphine at a dose effective in lesion-only animals to rats with nigral transplants
Note: Apomorphine had no additive effect in grafted rats
“Apomorphine, at a dose effective in the lesion-only animals, had no additive effect in the grafted rats”
Administer amphetamine to rats with intranigral transplants
Note: Amphetamine appeared to further improve stepping in rats with intranigral transplants
“amphetamine appeared to further improve stepping in the rats with intranigral transplants”
Conduct identical experiments on skilled forelimb use using the staircase test as a comparison task
Note: Neither dopamine agonist drugs nor nigral transplants had any effects on lesion-induced deficits in this more complex task
“Identical experiments were performed on skilled forelimb use in the so-called staircase test”
Monitor and assess forelimb stepping movements during the stepping test
Note: The stepping test is a highly useful test to monitor lesion- and transplant-induced changes in forelimb akinesia
“forelimb stepping is a highly useful test to monitor lesion-/and transplant-induced changes in forelimb akinesia”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
To assess forelimb akinesia and stepping movements in rats with unilateral 6-OHDA lesions of the dopamine system, and to evaluate the effectiveness of dopamine agonists and fetal dopamine neuron transplants in reversing these deficits
Objective
To assess forelimb akinesia and stepping movements in rats with unilateral 6-OHDA lesions of the dopamine system, and to evaluate the effectiveness of dopamine agonists and fetal dopamine neuron transplants in reversing these deficits
Subjects
From paperrat • Not specified • unknown • Not specified • Not specified
Cohort notes
From paperRats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the mesencephalic dopamine system
Create unilateral 6-OHDA lesion (Not specified)
Administer dopamine agonist - Apomorphine (Not specified)
Administer dopamine agonist - SKF 38393 (Not specified)
Administer dopamine agonist - Quinpirole (Not specified)
Initiation of stepping movements with the contralateral paw
From paperNot specified
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Forelimb akinesia severity
From paperNot specified
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Skilled forelimb use in staircase test
From paperNot specified
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Response to dopamine agonists (apomorphine, SKF 38393, quinpirole)
From paperNot specified
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Initiation of stepping movements with the contralateral paw
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Forelimb akinesia severity
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Skilled forelimb use in staircase test
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Response to dopamine agonists (apomorphine, SKF 38393, quinpirole)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
Not specified
Scoring or quantification
Quantify the primary readouts for this experiment: Initiation of stepping movements with the contralateral paw; Forelimb akinesia severity; Skilled forelimb use in staircase test; Response to dopamine agonists (apomorphine, SKF 38393, quinpirole).
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Initiation of stepping movements with the contralateral paw, Forelimb akinesia severity, Skilled forelimb use in staircase test, Response to dopamine agonists (apomorphine, SKF 38393, quinpirole).
Source links and direct wording from the methods section for validation and deeper review.
Citation
M Olsson et al. (1995). Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. Journal of Neuroscience
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Gather these items before starting the experiment. Check off items as you prepare.
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
12
Evidence Quotes
21
Protocol Items
9
Linked Products
0
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
12
Evidence
21
Specific Products
0/0
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.
What still needs work